We are Sorry, This Page doesn't Exist

Shares of Fate Therapeutics gained 37% after it shared promising data from one clinical and one preclinical study for its experimental cancer immunotherapy treatments. The company is testing two therapies, FT516 and FT500, in.....»»

Judy Chou will go from a multinational company that made everything from aspirin to hemophilia A treatments to a smaller company with multiple drugs in clinical trials......»»

As cancer care evolves with each new drug, treatment or therapy that emerges through important research, so too evolve the methods by which these discoveries are made......»»

This is known as the world’s largest clinical cancer conference, and it always delivers new results on clinical trials and updated treatments in the field. Not to mention, this conference has the........»»

Scholar Rock Holding Corp. shares dropped 11% in active Thursday trade after Pfizer Inc. announced it plans to stop two ongoing clinical trials for a similar rare-disease drug. The Pfizer drug in question, domagrozumab, w.....»»

Shares of Pieris Pharmaceuticals Inc. rocketed 57.3% on massive volume in afternoon trading Tuesday, after the Boston-based biotechnology company announced a respiratory and ophthalmology collaboration with Roche Holding AG's .....»»

The new cell therapy manufacturing facility, which will open early next year, will be able to deliver highly specialized cell therapies to patients in clinical trials at UCSF's women's, children's and cancer hospitals complex across Mariposa Street......»»

The Nation.....»»

Immatics NV (NASDAQ: IMTX) has announced a clinical data update from the dose-escalation cohorts of the ongoing Phase 1 trial evaluating its ACTengine product candidates IMA201, IMA202, and IMA read more.....»»

Roche Holding AG (OTC: RHHBY) acquired GenMark Diagnostics, Inc (NASDAQ: GNMK) in a read more.....»»

ShaShares of Eli Lilly & Co. were down 5.2% in premarket trading on Monday, two days after the drug maker said additional clinical-trial data reinforced the role its experi.....»»

Roche Holding AG (OTCMKT: RHHBF) has joined AstraZeneca Plc (NASDAQ: AZN) in withdrawing cancer immunotherapies from the U.S. read more.....»»

The National Institutes of Health said Thursday t.....»»

The National Institutes of Health said Thursday that it is putting three more investigational COVID-19 treatments into Phase 2/3 clinical trials. The experimental therapies are: an inhalable beta interferon developed .....»»

Shares.....»»

Despite recording year-over-year declines in fourth-quarter and full-year 2020 revenue, Airbnb Inc (NASDAQ: ABNB) is holding the confidence of analysts covering the .....»»

Shares of Cassava Sciences Inc. more than doubled toward a near 10-year high in very active trading Tuesday, after the company focused on neurodegenerative disease treatments announced upbeat results from a stu.....»»

Shares of Biogen Inc. gained 5.6% in trading on Monday after another drugmaker shared positive clinical data about an experimental Alzheimer's disease treatment that is similar to a Biogen therapy under review by the Food and Drug A.....»»

The company is a clinical-stage biopharmaceutical firm focused on developing new cancer immunotherapy treatments......»»

Shares of Veru Inc. soared 51.4% toward a seven-year high on massive volume, after the biopharmaceutical company announced positive results from a Phase 2 study of its treatment.....»»